The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sipovskiĭ V.G.

Nauchno-issledovatel'skiĭ institut nefrologii GBOU VPO "Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. akad. I.P. Pavlova"

Klemina I.K.

Research Institute of Nephrology, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of the Russian Federation, Saint Petersburg, Russia

Zverkov R.V.

Research Institute of Nephrology, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of the Russian Federation, Saint Petersburg, Russia

Dobronravov V.A.

Research Institute of Nephrology, I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of the Russian Federation, Saint Petersburg, Russia

Smirnov A.V.

Volgograd State Medical University, Volgograd, Russia

A case of diagnosing lipoprotein glomerulopathy in Russia

Authors:

Sipovskiĭ V.G., Klemina I.K., Zverkov R.V., Dobronravov V.A., Smirnov A.V.

More about the authors

Read: 2425 times


To cite this article:

Sipovskiĭ VG, Klemina IK, Zverkov RV, Dobronravov VA, Smirnov AV. A case of diagnosing lipoprotein glomerulopathy in Russia. Russian Journal of Archive of Pathology. 2016;78(6):52‑57. (In Russ.)
https://doi.org/10.17116/patol201678652-57

References:

  1. Smirnov A. Dislipoproteinemia and problems of nephroprotection. Nefrologiya. 2002;6(2):8-14. (In Russ.)
  2. Smirnov A. What are the current principles of using statins in patients with glomerulonephritis? Nefrologiya. 2002;6(1):108-110. (In Russ.)
  3. Saito T, Sato H, Kudo K, Oikawa S, Shibata T, Hara Y. et al. Lipoprpotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am. J. Kidney Dis. 1989;13(2):148-153. doi:10.1016/s0272-6386(89)80134-9
  4. Sakaguchi H, Mitarai T, Hirose S. Lipoprotein glomerulopathy: A novel glomerular disease presenting with peculiar morphological findings. Nippon Jinzo Gakki Shi. 1989;31:451-456.
  5. Amatruda JM, Margolis S, Hutchins GM. Type III hyperlipoproteinemia with mesangial foam cells in renal glomeruli. Arch. Pathol. 1974;98:51-54.
  6. Churg J, Bernstein J, Glassock RJ. Lipoprotein glomerulopathy. In: Renal disease: classification and atlas of glomerular disease. 2nd ed. New York, NY Igaku-Shoin; 1995:450-475.
  7. Magistroni R, Bertolotti M, Furci L, Fano RA, Leonelli M, Pisciotta L et al. Lipoprotein glomerulopathy associated with a mutation in apolipoprotein E. Clin. Med. Insights Case Rep. 2013;5(6):189-196. doi:10.4137/CCRep.S12209
  8. Pêgas KL, Rohde R, Garcia CD, Bittencourt V de B, Keitel E, Poloni JA, Cambruzzi E. Lipoprotein glomerulopathy: a case report of a rare disease in a Brazilian child. J Bras Nefrol. 2014;36(1):93-95.
  9. Miyata T, Sugiyama S, Nangaku M, Suzuki D, Uragami K, Inagi R et al. Apolopoprotein E2/E3 variants in lipoprotein glomerulopathy recurred in transplanted kidney. J Am Soc Nephrol. 1999;10(7):1590-1595.
  10. Saito T, Matsunaga A, Shinichi O. Impact of lipoprotein glomerulopathy on the relationship between Lipids and renal disease. Am J Kidney Dis. 2006;47(2):199-211. doi:10.1053/j.ajkd.2005.10.017
  11. Takemura T, Yoshioka K, Aya N, Murakami K, Matumoto A, Itakura H et al. Apolipoproteins and lipoprotein receptors inglomeruli in human kidney disease. Kidney Int. 1993;43(4):918-927.
  12. Sato H, Suzuki S, Kobayashi H, Ogino S, Inomata A, Arakawa M. Immunohistological localization of apolipoproteins in the glomeruli in renal disease: Specifically apoB and apoE. Clin Nephrol. 1991;36(3):127-133.
  13. Saito T, Sato H, Oikawa S. Lipoprotein glomerulopathy: A new aspect of lipid induced glomerular injury. Nephrology. 1995;1(1):17-24.
  14. Zang B, Liu ZH, Zeng CH, Zheng JM, Chen HP, Zhou H, Li LS. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy. Chin Med J. 2005;118(5):550-560.
  15. Fogo AB, Kashgarian M. Diagnostic atlas of renal pathology. 2nd ed. Elsevier; 2005:183-185. doi:10.1016/b978-1-4377-0427-3.00001-5
  16. Luo B, Huang F, Liu Q, Li X, Chen W, Zhou S.F, Yu X. Identification of apolipoprtotein E Guangzhou(arginine 150 proline),a new variant associated with lipoprotein glomerulopathy. Am J Nephrol. 2008;28(2):347-353. doi:10.1159/000111828
  17. Murano T, Matsumura R, Misawa Y, Ozaki H, Miyashita Y, Yoshida S et al. Interaction of endothelial cells and Trigliceride — rich lipoproteins with apolipoprotein E (Arg-Cys) from a patient with lipoprotein glomerulopathy. Metabolism. 2002;51(2):201-205.
  18. Ishigaki Y, Oikawa S, Suzuki T, Usui S, Magoori K, Kim DH et al. Virus mediated transduction of apoE-Sendai develops lipoprotein glomerulopathy in apo-E deficient mice. J Biol Chem. 2000;275(40):31269-31273. doi:10.1074/jbc.M005906200
  19. Takasaki S, Maeda K, Joh K, Yamakage S, Fukase S, Takahashi T et al. Macrophage infiltration into the glomeruli in lipoprotein glomerulopathy. Case Rep Nephrol Dial. 2015;5(3):204-212. doi:10.1159/000441715

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.